VentasVTR财报
NYSE · 房地产 · 医疗保健房地产投资信托基金
Ventas是一家领先的医疗地产投资信托企业，旗下资产涵盖养老社区、医疗办公楼、生命科学研究设施及康复医疗中心等，主要在北美、英国地区运营，为医疗服务及生命科学机构提供专业物业解决方案。
营收
$1.4B
毛利润
N/A
营业利润
$42.7M
净利润
$71.5M
毛利率
N/A
营业利润率
3.0%
净利率
5.0%
同比增长
18.3%
EPS
$0.15
Ventas 2025财年Q2 财务摘要
Ventas 2025财年Q2营收 $1.4B（同比增长 18.3%），净利润 $71.5M（同比增长 237.6%）（净利率 5.0%）。
核心财务指标
| 总营收 | $1.4B |
|---|---|
| 净利润 | $71.5M |
| 毛利率 | N/A |
| 营业利润率 | 3.0% |
| 报告期 | 2025财年Q2 |
营收拆解
Ventas 2025财年Q2营收 $1.4B 共来自 4 个业务板块，最大板块 Senior Housing Operating Portfolio SHOP 贡献 $1.0B（占 72.7%）。
| 业务分部 | 营收 | 占比 |
|---|---|---|
| Senior Housing Operating Portfolio SHOP | $1.0B | 72.7% |
| Outpatient Medical And Research Portfolio | $221.5M | 15.6% |
| Triple Net Leased Properties | $152.7M | 10.7% |
| Third Party Capital Management | $4.4M | 0.3% |
Ventas 分部营收 — 季度趋势
Ventas 过去 4 个季度各业务板块营收走势，展示 Senior Housing Operating Portfolio SHOP和Outpatient Medical And Research Portfolio 等业务的变化。
| 业务分部 | 2026财年Q1 | 2025财年Q4 | 2025财年Q3 | 2025财年Q2 |
|---|---|---|---|---|
| Senior Housing Operating Portfolio SHOP | — | — | $1.1B | $1.0B |
| Outpatient Medical And Research Portfolio | — | — | $226.9M | $221.5M |
| Triple Net Leased Properties | — | — | $160.1M | $152.7M |
| Third Party Capital Management | — | — | $4.5M | $4.4M |
Ventas 年度营收
Ventas 历年营收汇总，含各年度总量（例如 2025 年营收为 $5.8B）
| 年份 | 年营收 |
|---|---|
| 2025 | $5.8B |
| 2024 | $4.9B |
| 2023 | $4.5B |
| 2022 | $4.1B |
Ventas 季度营收与净利润历史
Ventas 最近 8 个季度的营收、净利润及同比增速
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| 2026财年Q1 | $1.7B | +22.0% | $59.0M | 3.6% |
| 2025财年Q4 | $1.6B | +21.7% | $73.0M | 4.7% |
| 2025财年Q3 | $1.5B | +20.4% | $68.7M | 4.6% |
| 2025财年Q2 | $1.4B | +18.3% | $71.5M | 5.0% |
| 2025财年Q1 | $1.4B | +13.2% | $48.4M | 3.6% |
| 2024财年Q4 | $1.3B | +10.5% | $58.7M | 4.6% |
| 2024财年Q3 | $1.2B | +7.5% | $21.0M | 1.7% |
| 2024财年Q2 | $1.2B | +8.6% | $21.2M | 1.8% |
利润表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $1.20B | $1.24B | $1.29B | $1.36B | $1.42B | $1.49B | $1.57B | $1.66B |
| 同比增长 | 8.6% | 7.5% | 10.5% | 13.2% | 18.3% | 20.4% | 21.7% | 22.0% |
资产负债表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $24.53B | $25.35B | $26.19B | $26.03B | $26.47B | $26.93B | $27.59B | $27.69B |
| 总负债 | $14.55B | $15.19B | $15.05B | $14.17B | $14.55B | $14.15B | $14.63B | $14.11B |
| 股东权益 | $9.62B | $9.76B | $10.77B | $11.47B | $11.53B | $12.36B | $12.53B | $13.18B |
现金流量表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| 经营性现金流 | $335.9M | $353.7M | $373.6M | $321.1M | $475.3M | $378.6M | $471.7M |